Human Liver Models Market Size & Share | Forecast by 2028

Human Liver Models Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Liver Organoids, Liver-on-a-Chip, 2D Models, 3D Bioprinting, and Others), Application (Drug Discovery, Educational, and Other), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others)

  • Report Code : TIPRE00025128
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 178
Buy Now

The human liver models market is projected to reach US$ 508.26 million by 2028 from US$ 233.90 million in 2021; it is expected to grow at a CAGR of 11.7% from 2021 to 2028.

The market's growth is primarily attributed to the increasing prevalence of liver diseases and the growing focus on developing alternatives for animal testing models. However, the high costs of human liver models and issues with incorporating liver models into existing workflow are hindering the Human Liver Models market growth. The liver is an important organ that performs vital body functions such as synthesis of blood clotting factors, bile production, protein production, and detoxification. Human liver models are used to study the drug's toxicity and enable understanding of the effect of drugs and the progression of liver disease. The rising focus on developing alternatives for the animal testing models is one of the major factors estimated to encourage the growth of the global human liver models in the next few years.

 

The Asia Pacific biopharmaceutical industry was disturbed for a few months of 2020, owing to the COVID-19 outbreak. The COVID-19 pandemic has affected clinical trials in an unparalleled manner due to multiple levels of restrictions imposed to control the spread of infection. However, with the rising demand for products to treat the COVID-19 infection, the biopharmaceutical and pharmaceutical companies in India and China have increased their research activities, which is positively impacting the market growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Human Liver Models Market: Strategic Insights

human-liver-models-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

 

Market Insights

Increasing Prevalence of Liver Diseases Fuel Human Liver Models Market Growth

The liver is the largest internal organ in the human body and performs over 500 functions. Liver toxicity is a major concern in risk assessment as the liver is exposed to most xenobiotic compounds and their bioactive metabolites, making it susceptible to chemically induced liver disease. Hepatitis C virus (HCV), chronic hepatitis B virus (HBV), nonalcoholic fatty liver disease (NAFLD), and alcohol-associated liver disease (ALD) are among the leading causes of chronic liver disease. Viral hepatitis continues to be the leading cause of death cases caused by liver failure, and at the same time, the NAFLD has become one of the fastest-growing contributors to liver morbidity and associated mortality. According to the national statistics of the UK, liver diseases have been ranked the fifth-leading cause of death in the country.

Furthermore, these diseases are considered the second-leading cause of death among all digestive diseases in the US. According to the American Association for the Study of Liver Diseases, in 2017, the global burden of liver cancer and cirrhosis had increased. The NAFLDs have an estimated prevalence of ~25% in the general population. Nearly a third of the US population has the NAFLD, and people with Type 2 diabetes mellitus or obesity are disproportionately affected; the number of cases with NAFLD is expected to increase from 83.1 million people in 2015 to 100.9 million by 2030. Thus, a rise in the global prevalence of liver diseases, including chronic and acute diseases and microbial infections, increases the demand for liver models.

Type-Based Insights

Based on type, the human liver models market is further segmented into liver organoids, liver-on-a-chip, 2D models, 3D bioprinting, and others. The liver organoids segment holds the largest share of the market. However, the liver-on-a-chip segment is anticipated to register the highest CAGR during 2021–2028. Advances in liver organoid technology provide models for prenatal development, tissue preservation, and pathologies, which would propel the market growth of this segment in the coming years.

Application-Based Insights

Based on application, the human liver models market is further segmented into educational, drug discovery, and others. The drug discovery segment holds the largest share of the human liver models market; however, the educational segment is anticipated to register the highest CAGR during the forecast period.

End User-Based Insights

Based on end user, the human liver models market is segmented into research institutes, pharmaceutical and biotechnology companies, and others. The pharmaceutical and biotechnology companies segment holds the largest market share. However, the research institutes segment is estimated to register the highest CAGR during the forecast period. The projected market growth for this segment can be attributed to an increase in collaborations between industry and universities for genome research and technological advances in the production of human liver models.

Companies operating in the human liver models market are adopting product innovations strategy to meet the evolving customer demands worldwide, which also permits them to maintain their brand name in the global market.

Human Liver Models Market Regional Insights

The regional trends and factors influencing the Human Liver Models Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Human Liver Models Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

human-liver-models-market-global-geography
  • Get the Regional Specific Data for Human Liver Models Market

Human Liver Models Market Report Scope

Report Attribute Details
Market size in 2021 US$ 233.90 Million
Market Size by 2028 US$ 508.26 Million
Global CAGR (2021 - 2028) 11.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Liver Organoids
  • Liver-on-a-Chip
  • 2D Models
  • 3D Bioprinting
By Application
  • Drug Discovery
  • Educational
By End User
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC INC.
  • Emulate, Inc.
  • CN Bio Innovations,
  • CYFUSE BIOMEDICAL K.K.
  • MIMETAS BV
  • InSphero
  • BioIVT
  • CELLINK
  • Kerafast
  • Market Players Density: Understanding Its Impact on Business Dynamics

    The Human Liver Models Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Human Liver Models Market are:

    1. THERMO FISHER SCIENTIFIC INC.
    2. Emulate, Inc.
    3. CN Bio Innovations,
    4. CYFUSE BIOMEDICAL K.K.
    5. MIMETAS BV

    Disclaimer: The companies listed above are not ranked in any particular order.


    human-liver-models-market-speedometer

    • Get the Human Liver Models Market top key players overview

     

    Human Liver Models Market – by Type

    • Liver Organoids
    • Liver-on-a-chip
    • 2D Models
    • 3D Bioprinting
    • Others

    Human Liver Models Market – by Application

    • Drug Discovery
    • Educational
    • Other 

    Human Liver Models Market – by End User

    • Pharmaceutical and Biotechnology Companies
    • Research Institutes
    • Others

    Human Liver Models Market – by Geography

    • North America

      • US
      • Canada
      • Mexico
    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East & Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)

      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • THERMO FISHER SCIENTIFIC INC.
    • Emulate, Inc.
    • CN Bio Innovations,
    • CYFUSE BIOMEDICAL K.K.
    • MIMETAS BV
    • InSphero
    • BioIVT
    • CELLINK
    • Kerafast
    • Cyprio
    • Kirkstall
    • ORGANOVO HOLDINGS INC    
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    Type, Application and End User

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    Frequently Asked Questions


    Which segment is growing at the highest CAGR in the human liver models market?

    The liver-on-a-chip segment is growing at the highest CAGR owing to increasing demand for cost-effective alternatives to animal models for drug research and development.

    Which region is the fastest growing in the human liver models market?

    Asia Pacific is expected to be the fastest growing region in the Human Liver Models market. The growth of the market in this region is primarily due to growing biopharmaceutical industry, increasing number of clinical trials, and increasing research activities for the development of innovative therapies.

    Which region is dominated the human liver models market?

    North America dominates the global human liver models market due to factors such as increasing incidences of the liver diseases such as cirrhosis, chronic liver disease (CLD), Nonalcoholic fatty liver disease (NAFLD) and others across the country. Moreover, the growth of market in Canada is expected to grow due to increasing support from the government to address the rising concerns about the liver diseases.

    What are the driving factors for the human liver models market across the globe?

    The factors that are driving growth of the market are increasing prevalence of liver diseases, and growing focus on developing alternatives for animal testing models.

    Who are the developments carrying out by major players in the human liver models market?

    Various companies have made organic growth strategies in the human liver models market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as InSphero, Emulate, Inc amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies - Human Liver Models Market

    1. THERMO FISHER SCIENTIFIC INC.
    2. Emulate, Inc.
    3. CN Bio Innovations,
    4. CYFUSE BIOMEDICAL K.K.
    5. MIMETAS BV
    6. InSphero
    7. BioIVT
    8. CELLINK
    9. Kerafast
    10. Cyprio
    11. Kirkstall
    12. ORGANOVO HOLDINGS INC